Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinchan Zhiyang is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Chongqing Searainbow Pharmaceutical Co., Ltd. It is primarily indicated for the treatment of subacute eczema and various pruritic (itchy) skin conditions. The medication is formulated based on TCM principles to clear heat, eliminate dampness, and relieve itching (Qingre Qushi, Zhiyang). It typically contains a combination of herbal ingredients, including *Periostracum Cicadae* (Cicada Slough), *Radix Sophorae Flavescentis* (Kushen), and *Fructus Kochiae* (Di Fu Zi). Pharmacologically, it is thought to exert anti-inflammatory and anti-allergic effects by modulating immune responses and reducing the release of inflammatory mediators in the skin. It is commonly administered orally in the form of capsules or granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinchan Zhiyang.